Catalyst Pharmaceuticals Inc
CPRX
Market Cap$2.52B
Close$
$16.80
15.2% downside
Current Fair Value
15.2% downsideOvervalued by 15.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.52 Billion |
|---|---|
| Enterprise Value | $1.87 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $1.38 |
| Beta | 0.7 |
| Outstanding Shares | 122,163,212 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 12.05 |
|---|---|
| PEG | 43.46 |
| Price to Sales | 4.95 |
| Price to Book Ratio | 2.83 |
| Enterprise Value to Revenue | 3.37 |
| Enterprise Value to EBIT | 7.6 |
| Enterprise Value to Net Income | 8 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Catalyst Pharmaceuticals Inc
CEO: Patrick McEnany